Bosutinib in Adult Patients With Recurrent Glioblastoma

NCT01331291 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: bosutinib

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]